
CAS 158040-83-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 produits concernés.
IFN-γ Antagonist
CAS :This peptide derived from the ligand binding site of the human γ-interferon (IFN-γ) receptor is an antagonist of human IFN-γ. It inhibited human IFN-γ-induced expression of HLR/DR antigen on Colo 205 cells with an approximate IC₅₀ of 35 µM. Immobilized peptide specifically bound recombinant human IFN-γ. Tyrosine substitution at residue 121 allowed facile quantification and conjugation of the peptide.Formule :C115H194N34O34SDegré de pureté :> 98%Couleur et forme :White LyophilisateMasse moléculaire :2629.08IFN-γ Antagonist 1
CAS :IFN-γ Antagonist 1 (AYCRDGKIGPPKLDIRKEEKQI), an interferon γ (IFN γ) antagonist, effectively inhibits IFN-γ induced HLR/DR antigen expression in Colon 205 cellsFormule :C115H194N34O34SCouleur et forme :SolidMasse moléculaire :2629.04IFN-gamma Antagonist
CAS :<p>IFN-gamma antagonist is a regulatory protein that inhibits the activation of IFN-gamma. Activated, or "switched on", IFN-gamma is necessary for the replication of viruses, such as influenza virus. The mechanism of action of this molecule involves binding to and blocking the receptor site for IFN-gamma. This prevents the binding of activated IFN-gamma to its receptor, thereby preventing activation and replication of viruses in cells. IFN-gamma antagonists may also be used to treat cancer in humans as well as other diseases that are regulated by this cytokine.</p>Formule :C115H194N34O34SDegré de pureté :Min. 95%Masse moléculaire :2,629.05 g/mol



